Rhythm Biosciences Revenue

Rhythm Biosciences had revenue of 1.62M AUD in the half year ending December 31, 2025, a decrease of -4.02%. This brings the company's revenue in the last twelve months to 1.65M, down -47.96% year-over-year. In the fiscal year ending June 30, 2025, Rhythm Biosciences had annual revenue of 3.19M with 88.85% growth.

Revenue (ttm)

1.65M

Revenue Growth

-47.96%

P/S Ratio

39.81

Revenue / Employee

n/a

Employees

n/a

Market Cap

65.60M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	3.19M	1.50M	88.85%
Jun 30, 2024	1.69M	-1.41M	-45.41%
Jun 30, 2023	3.10M	668.44K	27.54%
Jun 30, 2022	2.43M	1.32M	118.98%
Jun 30, 2021	1.11M	1.01M	1,008.51%
Jun 30, 2020	Pro	Pro	Pro
Jun 30, 2019	Pro	Pro	Pro
Jun 30, 2018	Pro	Pro	Pro
Jun 30, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Cryosite	15.75M
Microba Life Sciences	14.90M
INOVIQ	2.10M
BCAL Diagnostics	2.54M
Genetic Signatures	19.94M
Monash IVF Group	269.39M
Imagion Biosystems	73.03K
Australian Clinical Labs	737.49M

Revenue Rankings